In this issue:
Low-dose alemtuzumab + rituximab for GVHD
DA-EPOCH-R in DLBCL, with molecular subtype analysis
H. pylori eradication in early-stage
H pylori-positive gastric DLBCL
Lenalidomide, cyclophosphamide and dexamethasone in light-chain amyloidosis
IgA and IgM abn
Please login below to download this issue (PDF)